ProfileGDS4718 / 216251_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 94% 92% 81% 93% 90% 92% 93% 94% 90% 91% 91% 91% 92% 91% 91% 90% 91% 89% 92% 83% 92% 92% 92% 92% 92% 90% 91% 90% 91% 93% 87% 89% 91% 92% 82% 90% 93% 92% 93% 76% 92% 89% 88% 88% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.092794
GSM549102patient 115, normal, homogenized [OPG study]9.5994492
GSM549104patient 119, normal, homogenized [OPG study]8.0617981
GSM549108patient 138, normal, homogenized [OPG study]9.6543793
GSM549119patient 077, normal, homogenized [OPG study]9.2554590
GSM549133patient 032, cancer, homogenized [OPG study]9.6794492
GSM549139patient 042, cancer, homogenized [OPG study]9.7651693
GSM549099patient 107, normal, homogenized [OPG study]9.844894
GSM549109patient 139, normal, homogenized [OPG study]9.1801490
GSM549110patient 046, normal, homogenized [OPG study]9.4992391
GSM549114patient 063, normal, homogenized [OPG study]9.5955591
GSM549122patient 082, normal, homogenized [OPG study]9.4758991
GSM549134patient 033, cancer, homogenized [OPG study]9.6113792
GSM549136patient 036, cancer, homogenized [OPG study]9.4081391
GSM549140patient 044, cancer, homogenized [OPG study]9.397391
GSM549111patient 047, normal, homogenized [OPG study]9.2948790
GSM549113patient 057, normal, homogenized [OPG study]9.5361391
GSM549132patient 031, cancer, homogenized [OPG study]8.994789
GSM549137patient 038, cancer, homogenized [OPG study]9.5510992
GSM549142patient 047, cancer, homogenized [OPG study]7.9203883
GSM549100patient 110, normal, homogenized [OPG study]9.6416692
GSM549107patient 135, normal, homogenized [OPG study]9.751792
GSM549115patient 068, normal, homogenized [OPG study]9.6942392
GSM549116patient 072, normal, homogenized [OPG study]9.6236292
GSM549120patient 078, normal, homogenized [OPG study]9.6286392
GSM549131patient 030, cancer, homogenized [OPG study]9.2567890
GSM549118patient 074, normal, homogenized [OPG study]9.4870591
GSM549129patient 027, cancer, homogenized [OPG study]9.1573990
GSM549123patient 088, normal, homogenized [OPG study]9.4290491
GSM549124patient 006, cancer, homogenized [OPG study]9.6058493
GSM549126patient 015, cancer, homogenized [OPG study]8.6532387
GSM549128patient 025, cancer, homogenized [OPG study]9.0541689
GSM549103patient 117, normal, homogenized [OPG study]9.3279591
GSM549117patient 073, normal, homogenized [OPG study]9.720692
GSM549138patient 041, cancer, homogenized [OPG study]8.116582
GSM549141patient 045, cancer, homogenized [OPG study]9.1889990
GSM549130patient 028, cancer, homogenized [OPG study]9.5964593
GSM549101patient 111, normal, homogenized [OPG study]9.4614592
GSM549105patient 128, normal, homogenized [OPG study]9.6550293
GSM549106patient 134, normal, homogenized [OPG study]7.5946676
GSM549112patient 048, normal, homogenized [OPG study]9.7048592
GSM549125patient 011, cancer, homogenized [OPG study]9.0351189
GSM549127patient 024, cancer, homogenized [OPG study]8.8194988
GSM549135patient 035, cancer, homogenized [OPG study]8.9976188